Many forms of cardiomyopathy are hereditary. Depending on the type, anywhere from 25% to 60% of cases can be traced to a genetic cause, and the condition most often passes from parent to child in a pattern where inheriting just one copy of the altered gene is enough to develop the disease. That said, not everyone who carries a disease-causing gene variant will develop symptoms, and some forms of cardiomyopathy are caused by factors that have nothing to do with genetics, like long-term high blood pressure, alcohol use, or viral infections.
Which Types Are Most Often Inherited
The four major types of cardiomyopathy with known genetic links are hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), arrhythmogenic right ventricular cardiomyopathy (ARVC), and restrictive cardiomyopathy (RCM). Each has a distinct set of gene mutations and slightly different odds of running in families.
Hypertrophic cardiomyopathy is the most common inherited form, affecting roughly 1 in 200 to 500 people. In this condition, the heart muscle thickens abnormally, making it harder for the heart to pump. Genetic mutations in proteins that make up the heart’s contractile machinery are responsible for 30% to 40% of cases. When researchers test adolescents and adults with HCM, they find a disease-causing gene variant 40% to 60% of the time. The two most frequently involved genes code for proteins in the thick filament of the heart muscle cell. Mutations in one gene tend to produce an abnormal protein that gets built into the muscle and disrupts function directly, while mutations in the other lead to a shortage of a key structural protein. Both result in a heart that contracts too forcefully and relaxes poorly.
Dilated cardiomyopathy causes the heart’s main pumping chamber to stretch and weaken. Clinical evaluation finds that 30% to 50% of people with DCM have a relative who is also affected or likely affected. Variations in more than 40 genes have been linked to DCM, but the single biggest genetic contributor is mutations in the gene for titin, a giant spring-like protein that helps heart muscle generate force. Titin mutations show up in about 25% of familial DCM cases and 18% of cases with no known family history.
Arrhythmogenic right ventricular cardiomyopathy is rarer (affecting 1 in 2,000 to 5,000 people) but carries a high risk of dangerous heart rhythms and sudden cardiac death. About half of genetically identified ARVC cases stem from mutations in five genes that encode desmosomal proteins, the molecular “rivets” that hold heart muscle cells together. When these connections weaken, heart muscle is gradually replaced by fat and scar tissue, disrupting electrical signals.
Restrictive cardiomyopathy is the least common form. The heart muscle becomes stiff, limiting how much blood fills the chambers between beats. It can be inherited alongside HCM and DCM through overlapping genetic pathways, though it also has non-genetic causes like certain storage diseases.
How the Genes Are Passed Down
The most common inheritance pattern for HCM, DCM, and ARVC is autosomal dominant. This means you only need to inherit one altered copy of the gene, from either parent, to be at risk. If a parent carries a disease-causing mutation, each of their children has a 50% chance of inheriting it.
Less commonly, cardiomyopathy can follow other patterns. Some forms are autosomal recessive, requiring a defective gene from both parents. Others are X-linked, meaning the gene sits on the X chromosome and tends to affect males more severely. A small number of cases trace to mutations in mitochondrial DNA, which is inherited exclusively from the mother. These non-dominant forms tend to appear earlier in life and often cause more severe disease.
Carrying the Gene Doesn’t Guarantee Disease
One of the trickiest aspects of hereditary cardiomyopathy is something geneticists call incomplete penetrance. You can carry a known disease-causing mutation and never develop symptoms, or develop them decades later than a sibling with the same mutation. In a large study tracking adults over a median of eight years, about 46% of known gene carriers eventually showed signs of disease. When researchers looked at people in the general population who happened to carry a pathogenic variant but had no family history prompting the test, only about 11% showed evidence of the condition.
By contrast, when family members are specifically screened because a relative is already affected, penetrance climbs to roughly 57%. This gap likely reflects a combination of genetic background, lifestyle factors, and the intensity of monitoring. The practical takeaway: a positive genetic test raises your risk significantly, but it is not a certainty.
How Genetic Testing Works
Genetic testing for cardiomyopathy typically starts with the person who already has a diagnosis (called the proband). A blood or saliva sample is analyzed for mutations in a panel of genes associated with the specific type of cardiomyopathy. If a disease-causing variant is found, first-degree relatives (parents, siblings, children) can then be tested for that specific mutation through what’s called cascade genetic testing.
Before testing, a genetic counselor will walk you through what the results could mean, including the possibility of uncertain findings. Sometimes a variant is identified that hasn’t been definitively classified as harmful or harmless. These “variants of uncertain significance” can be frustrating because they don’t give a clear answer. Current guidelines recommend rechecking the classification of any detected variant every two to three years, since scientific understanding of these mutations improves over time.
If no genetic cause is found in the affected family member, that doesn’t rule out a hereditary component. Current testing panels only identify mutations in 20% to 30% of DCM patients and 30% to 40% of HCM patients, meaning a significant portion of genetic causes remain undiscovered.
Screening for Family Members
If you have a first-degree relative with cardiomyopathy, screening can start at any age. For families where a specific gene mutation has been identified, a simple genetic test can determine whether you carry it. If you test negative for the family’s known mutation, you can generally be released from ongoing cardiac monitoring.
For family members who test positive for the mutation but show no signs of disease yet (genotype-positive, phenotype-negative), regular heart imaging and electrical testing are recommended. Children and adolescents are typically screened more frequently because the heart is still growing and changing. The risk of developing the disease is highest during adolescence and young adulthood, though it can appear at any age. Most physicians continue periodic screening into the mid-50s, since late-onset cases do occur, though the frequency of visits can be reduced after age 18.
Why It Matters More in Children
Cardiomyopathy that appears in childhood tends to be more aggressive than adult-onset disease. Children diagnosed with HCM face a higher risk of life-threatening heart rhythm problems and are more likely to need advanced heart failure treatments compared to those diagnosed as adults. Over 50% of children with HCM have a family history of the condition, but only about 20% are symptomatic at diagnosis, meaning many cases are caught through family screening rather than because the child felt unwell.
Age at diagnosis plays a major role in outlook. Children diagnosed before their first birthday have a five-year survival rate of about 80.5%, though those who survive past the first year tend to follow a more favorable course. Children and young adults with confirmed genetic mutations in heart muscle protein genes face roughly double the risk of serious complications compared to those without an identifiable genetic cause.
Genetic vs. Acquired Cardiomyopathy
Not all cardiomyopathy is inherited. The heart muscle can weaken or stiffen from causes that have nothing to do with your DNA: chronic high blood pressure, coronary artery disease, heavy alcohol use, certain chemotherapy drugs, viral infections, and metabolic conditions like uncontrolled thyroid disease. Some conditions that mimic genetic cardiomyopathy, like Fabry disease (a storage disorder) or cardiac changes from intense athletic training, need to be ruled out during evaluation.
Distinguishing inherited from acquired cardiomyopathy matters because it changes the approach. A genetic diagnosis triggers family screening and potentially alters long-term monitoring and treatment decisions. An acquired diagnosis shifts the focus to treating the underlying cause. In practice, the line isn’t always clean. Some people have a genetic predisposition that only manifests when an environmental trigger, like a viral infection or pregnancy, adds extra stress to the heart.